NEUCA S.A. (NEU.WA) has a MoatMap StockRank of 86/100 based on Quality (56/100), Value (60/100), and Momentum (54/100) factor scores. The current signal is STRONG BUY. NEUCA is Poland's leading pharmaceutical wholesaler. It is a high-quality defensive business with dominant market share, but it operates in a low-margin industry and lacks direct alignment with our high-conviction global macro themes.
NEUCA S.A. distributes pharmaceuticals to independent pharmacies, hospitals, and medical clinics in Poland. The company is the absolute market leader in Polish pharmaceutical distribution, holding a dominant market share and offering integrated clinical trial services. It is a highly stable, defensive market leader with a unique business model focused on supporting independent pharmacies.
| Price | $198.25 |
| Market Cap | $914M |
| P/E (TTM) | 18.83 |
| P/E (Forward) | 13.16 |
| Price/Book | 2.82 |
| Return on Equity | 12.4% |
| Return on Invested Capital | 17.1% |
| Debt/Equity | 59.10 |
| Gross Margin | 11.5% |
| Operating Margin | 2.7% |
| Revenue Growth | 5.7% |
| Dividend Yield | 2.5% |
| Free Cash Flow | $20M |
NEUCA S.A. operates in the Medical Distribution industry, part of the Healthcare sector (Poland).